A 28-week Safety Study of Flibanserin in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder
NCT01103362
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
596
Enrollment
INDUSTRY
Sponsor class
Stopped
administrative reasons
Conditions
Sexual Dysfunctions, Psychological
Interventions
DRUG:
flibanserin
Sponsor
Sprout Pharmaceuticals, Inc